middle.news
How Island Pharmaceuticals Is Targeting Measles and More with Burnet Collaboration
9:58am on Monday 9th of March, 2026 AEDT
•
Healthcare
Read Story
How Island Pharmaceuticals Is Targeting Measles and More with Burnet Collaboration
9:58am on Monday 9th of March, 2026 AEDT
Key Points
Strategic collaboration with Burnet Institute to expand ISLA-101 and Galidesivir indications
Focus on measles, chikungunya, and Ross River virus; viruses with no current treatments
Alignment with national biodefence and public health stockpile priorities
Research led by Dr Johanna Fraser, co-inventor of ISLA-101, supported by $780,000+ NHMRC grant
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Island Pharmaceuticals (ASX:ILA)
OPEN ARTICLE